Cyprus: Medicover completes acquisition of NIPD Genetics

Fredrik Rågmark, chief executive of Medicover

Nasdaq-Stockholm listed Medicover, a specialised provider of diagnostic and healthcare services, focusing on markets mainly in Central and Eastern Europe and India, has announced the completion of the NIPD Genetics acquisition announced in December 2021. NIPD Genetics is a leading innovative biotechnology company based in Cyprus, active in the field of designing, developing, producing, and…

You must be a HMI Subscriber to view this content.

Subscribe Now »